Subversion of Ras Small GTPases in Cutaneous Melanoma Aggressiveness

Area of Science:

• Oncology
• Molecular Biology
• Dermatology

Background:

• Cutaneous melanoma presents a significant public health challenge due to increasing incidence and mortality.
• The molecular underpinnings of melanoma metastasis remain poorly understood, limiting therapeutic efficacy.
• There is a critical need for novel biomarkers for prognosis, metastasis, and treatment response in melanoma.

Purpose of the Study:

• To review the current understanding of Ras small GTPases' role in melanoma aggressiveness.
• To elucidate the molecular mechanisms by which Ras small GTPases contribute to melanoma progression and metastasis.
• To summarize the influence of Ras small GTPases on melanoma metastasis and response to therapy.

Main Methods:

• Literature review of studies on Ras small GTPases in melanoma.
• Analysis of molecular mechanisms regulating melanoma tumorigenesis and progression.
• Synthesis of data on the involvement of Ras small GTPases in melanoma metastasis and therapy response.

Main Results:

• Ras small GTPases are differentially expressed and their functions are subverted in melanoma.
• These proteins play a significant role in regulating melanoma cell signaling, invasion, and cytoskeleton dynamics.
• Dysregulation of Ras small GTPases is implicated in melanoma aggressiveness and metastatic potential.

Conclusions:

• Ras small GTPases are key regulators of melanoma progression, invasion, and metastasis.
• Targeting Ras small GTPase pathways may offer novel therapeutic strategies to combat melanoma.
• Further research into these molecular players is essential for improving melanoma patient outcomes.